BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28742501)

  • 1. Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes.
    Nicolaides NC; Charmandari E
    Hormones (Athens); 2017 Apr; 16(2):124-138. PubMed ID: 28742501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance.
    Nicolaides N; Lamprokostopoulou A; Sertedaki A; Charmandari E
    Hormones (Athens); 2016; 15(1):23-34. PubMed ID: 27086682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.
    Charmandari E; Kino T; Chrousos GP
    Endocr Dev; 2013; 24():67-85. PubMed ID: 23392096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response.
    Charmandari E
    Sci Signal; 2012 Oct; 5(244):pt5. PubMed ID: 23033539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
    Charmandari E; Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary generalized glucocorticoid resistance and hypersensitivity.
    Charmandari E
    Horm Res Paediatr; 2011; 76(3):145-55. PubMed ID: 21912096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular aspects of glucocorticoid sensitivity].
    Faria CD; Longui CA
    Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):983-95. PubMed ID: 17221103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update.
    Nicolaides NC; Charmandari E
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue glucocorticoid resistance/hypersensitivity syndromes.
    Kino T; De Martino MU; Charmandari E; Mirani M; Chrousos GP
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):457-67. PubMed ID: 12943736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of natural human glucocorticoid receptor (hGR) mutations or polymorphisms and their functional consequences at the hormone-receptor interaction level.
    Charmandari E; Chrousos GP; Kino T
    Methods Mol Biol; 2009; 590():33-60. PubMed ID: 19763496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids.
    Kino T
    Horm Metab Res; 2007 Jun; 39(6):420-4. PubMed ID: 17578758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient generalized glucocorticoid hypersensitivity.
    Nicolaides NC; Lamprokostopoulou A; Polyzos A; Kino T; Katsantoni E; Triantafyllou P; Christophoridis A; Katzos G; Dracopoulou M; Sertedaki A; Chrousos GP; Charmandari E
    Eur J Clin Invest; 2015 Dec; 45(12):1306-15. PubMed ID: 26479047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.
    Nicolaides NC; Roberts ML; Kino T; Braatvedt G; Hurt DE; Katsantoni E; Sertedaki A; Chrousos GP; Charmandari E
    J Clin Endocrinol Metab; 2014 May; 99(5):E902-7. PubMed ID: 24483153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways.
    Sevilla LM; Jiménez-Panizo A; Alegre-Martí A; Estébanez-Perpiñá E; Caelles C; Pérez P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel causes of generalized glucocorticoid resistance.
    Charmandari E; Kino T
    Horm Metab Res; 2007 Jun; 39(6):445-50. PubMed ID: 17578762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid Resistance.
    Nicolaides NC; Charmandari E
    Exp Suppl; 2019; 111():85-102. PubMed ID: 31588529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
    Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.
    Charmandari E; Kino T; Ichijo T; Jubiz W; Mejia L; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3986-90. PubMed ID: 17635946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
    Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
    Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of the hGRαT556I causing Chrousos syndrome.
    Nicolaides NC; Skyrla E; Vlachakis D; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
    Eur J Clin Invest; 2016 Jan; 46(1):42-9. PubMed ID: 26541474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.